40
Participants
Start Date
January 31, 2014
Primary Completion Date
February 28, 2015
Study Completion Date
February 28, 2015
Agomelatine
Participants who are randomly assigned to the agomelatine group will be treated with agomelatine oral tablets for twelve weeks. Participants will begin their agomelatine treatment at 25mg/day dosage, increasing to 50mg/day as clinically indicated.
Escitalopram
Participants who are randomly assigned to the escitalopram group will be treated with escitalopram oral tablets for twelve weeks. Participants will begin their escitalopram treatment at 10mg/day dosage, increasing to 20mg/day as clinically indicated.
Alfred and Baker Medical Unit - Alfred Hospital, Melbourne
Baker IDI Heart & Diabetes Institute, Melbourne
Monash Medical Centre - Monash Health, Clayton
Collaborators (1)
Servier Laboratories (Australia) Pty Ltd
UNKNOWN
The Alfred
OTHER
Monash Medical Centre
OTHER
Baker Heart and Diabetes Institute
OTHER